Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Etiology of IBD—Is It Still a Mystery?
Anna Kofla-Dłubacz, Tomasz Pytrus, Katarzyna Akutko, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12445-12445
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

The Emerging Role of Raman Spectroscopy as an Omics Approach for Metabolic Profiling and Biomarker Detection toward Precision Medicine
Gabriel Cutshaw, Saji Uthaman, Nora Hassan, et al.
Chemical Reviews (2023) Vol. 123, Iss. 13, pp. 8297-8346
Open Access | Times Cited: 72
Macrophage polarization in inflammatory bowel disease
Kun Zhang, Jing Guo, Wenlong Yan, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 49
Inflammation, Autoinflammation and Autoimmunity in Inflammatory Bowel Diseases
Andrea Padoan, Giulia Musso, Nicole Contran, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 7, pp. 5534-5557
Open Access | Times Cited: 33
Hypoxia and Intestinal Inflammation: Common Molecular Mechanisms and Signaling Pathways
Kristina A. Dvornikova, Olga N. Platonova, E. Yu. Bystrova
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2425-2425
Open Access | Times Cited: 23
Immunogenicity and Loss of Effectiveness of Biologic Therapy for Inflammatory Bowel Disease Patients Due to Anti-Drug Antibody Development
Tsvetelina Velikova, Metodija Sekulovski, Monika Peshevska-Sekulovska
Antibodies (2024) Vol. 13, Iss. 1, pp. 16-16
Open Access | Times Cited: 11
Disproportionality analysis of upadacitinib-related adverse events in inflammatory bowel disease using the FDA adverse event reporting system
Shiyi Wang, Xiaojian Wang, Jing Ding, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1
Inflammatory Bowel Disease: Crosstalk between Histamine, Immunity, and Disease
Kristina A. Dvornikova, Olga N. Platonova, E. Yu. Bystrova
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9937-9937
Open Access | Times Cited: 18
The Anti-inflammatory Potential of a Strain of Probiotic Bifidobacterium pseudocatenulatum G7: In Vitro and In Vivo Evidence
Yukun Sun, Jiazhi Zhou, Hengjun Du, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 18, pp. 10355-10365
Closed Access | Times Cited: 8
COVID-19 vaccinations in patients with chronic liver disease – experience of a tertiary centre in Melbourne
Annie Zhou, Hanyi Huang, Shivangi Gupta, et al.
Journal of Gastrointestinal and Liver Diseases (2024) Vol. 33, Iss. 1, pp. 131-132
Open Access | Times Cited: 7
The intestinal epithelial-macrophage-crypt stem cell axis plays a crucial role in regulating and maintaining intestinal homeostasis
Xiaohui Hu, Xinyi Yuan, Guokun Zhang, et al.
Life Sciences (2024) Vol. 344, pp. 122452-122452
Closed Access | Times Cited: 6
Adverse Food Reactions in Inflammatory Bowel Disease: State of the Art and Future Perspectives
I. Capobianco, Federica Di Vincenzo, Pierluigi Puca, et al.
Nutrients (2024) Vol. 16, Iss. 3, pp. 351-351
Open Access | Times Cited: 5
Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation
Mohamed Salla, Jimmy A. Guo, Harshad Joshi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5967-5967
Open Access | Times Cited: 11
Immunoregulatory effects of Huaier (Trametes robiniophila Murr) and relevant clinical applications
Hongrong Long, Zhongcai Wu
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Artemisia argyi Polyphenols Attenuates DSS-induced Colitis in Mice by Regulating the Structural Composition of Gut Microbiota
H.P. Zhang, Zhonghua Hao, Ruya Zhang, et al.
Phytomedicine (2024) Vol. 132, pp. 155897-155897
Closed Access | Times Cited: 4
Type I Arabinogalactan and Methyl-Esterified Homogalacturonan Polysaccharides from Tamarillo (Solanum betaceum cav.) Fruit Pulp Ameliorate DSS-Induced Ulcerative Colitis
Lara Luisa Valerio de Mello Braga, Carolina Silva Schiebel, Gisele Simão, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 461-461
Open Access
The critical role of COL1A1 revealed by integrated bioinformatics analysis of differentially-expressed genes in colorectal cancer and inflammatory bowel disease
Michael Pawlak, Żaneta Kałuzińska‐Kołat, Zbigniew Pasieka, et al.
Computers in Biology and Medicine (2025) Vol. 190, pp. 110116-110116
Closed Access
Therapeutic intervention with anti-TNF alleviates colonic and hepatic toxicity induced by perfluorooctanoic acid (PFOA)
Wei Li, Yongjing Qian, Xiaojing Cai, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 296, pp. 118125-118125
Closed Access
Antioxidant and anti-inflammatory effects of Equisetum arvense L. on acid-induced ulcerative colitis in rats
Omid Koohi‐Hosseinabadi, Farhad Koohpeyma, Ali Reza Safarpour, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Enrichment of 3D-Printed k-Carrageenan Food Gel with Callus Tissue of Narrow-Leaved Lupin Lupinus angustifolius
Kseniya Belova, Elena Dushina, Sergey V. Popov, et al.
Gels (2023) Vol. 9, Iss. 1, pp. 45-45
Open Access | Times Cited: 10
Molecular Mechanisms Underlying IL-33-Mediated Inflammation in Inflammatory Bowel Disease
Ιωάννα Αγγελετοπούλου, Efthymios P. Tsounis, Christos Triantos
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 623-623
Open Access | Times Cited: 16
Cardiovascular manifestations of inflammatory bowel diseases and the underlying pathogenic mechanisms
Ying Xiao, Don W. Powell, Xiaowei Liu, et al.
AJP Regulatory Integrative and Comparative Physiology (2023) Vol. 325, Iss. 2, pp. R193-R211
Open Access | Times Cited: 7
Mechanisms of Si-Wu Decoction in the treatment of ulcerative colitis revealed by network pharmacology and experimental verification
Lin Wang, Ya Liu, Guiyan Shen, et al.
Journal of Ethnopharmacology (2023) Vol. 317, pp. 116847-116847
Closed Access | Times Cited: 7
10 years of biologic use patterns in patients with inflammatory bowel disease: treatment persistence, switching and dose intensification – a nationwide population-based study
Hee Moon Koo, Yu Kyung Jun, Yonghoon Choi, et al.
Therapeutic Advances in Gastroenterology (2023) Vol. 16
Open Access | Times Cited: 7
A Review of Ophthalmic Complications in Inflammatory Bowel Diseases
Wiktoria Pytrus, Katarzyna Akutko, Tomasz Pytrus, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 24, pp. 7457-7457
Open Access | Times Cited: 11
Associations of iron metabolism and inflammation with all-cause and cardiovascular mortality in a large NHANES community sample: Moderating and mediating effects
Yaoting Zhang, Bing Li, He Cai, et al.
Nutrition Metabolism and Cardiovascular Diseases (2024) Vol. 34, Iss. 8, pp. 1854-1863
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top